Hufeland Klinikum GmbH, with its Mühlhausen and Bad Langensalza locations, is planning to introduce electronic care and treatment documentation (funding element 3) in direct connection with digital medication management (funding element 5) within the framework of the Hospital Future Act (KHZG).
The Hufeland Klinikum operates a total of around 450 inpatient beds on around 20 nursing wards. Every year, more than 190 doctors and more than 370 nurses treat around 22,000 inpatients in more than 20 specialist departments.
The overarching project goals with the implementation of a continuous, structured electronic patient record and digital medication are to ensure the constant availability of care and treatment documentation across all areas and departments of the hospital and thus to reduce the time spent by the professional groups involved. This is intended to achieve both an increase in the quality of treatment and an optimization of the treatment process. The diverse performance, communication and coordination processes in hospitals are also to be made more efficient and transparent outside the inpatient sector (discharge and overperformance management). In addition, digital medication management is intended to increase drug therapy safety and patient safety. Electronic medication must be fully integrated into the nursing and medical documentation process. Medication management should include the current medication plan according to § 31a SGB V and § 358 SGB V and check the respective prescriptions for contraindications, administration and possible alternatives.
The KIS, RIS/PACS (Dedalus) and PDMS (Meierhofer) systems already available at the Hufeland Klinikum are to be expanded by the electronic patient curve and digital medication and developed into a complete system with a continuous EPA/PDMS system by providing a fully mobile ward round using comprehensive WLAN. Interoperability of the various systems is essential.
Within the framework of the project described, the requirements of § 19 para. 2 KHSFV must be fully complied with. Furthermore, the MUST criteria specified in the funding guideline for digital care and treatment documentation and for digital medication must be met.
See point II.1.4.